IAG933, a selective YAP1/TAZ-panTEAD PPI inhibitor
Time: 10:15 am
day: Conference Day One
Details:
- The development and characterization of a direct pan-TEAD PPI inhibitor, IAG933
- Preclinical data supporting efficacy with IAG933
- Discovery of promising targeted therapy combinations with IAG933
